Affinity chromatography resins employ target-specific ligands attached to a stationary phase and are commonly used to capture therapeutic entities in biologics manufacturing, reducing the number of required purification steps and increasing overall yield.
A less common but powerful use of affinity purification is the removal of problematic impurities, such as host cell proteins. Both techniques require high-specificity affinity ligands with sufficient capacity, stability, and suitability for clinical manufacturing.
In this webinar, we present the development of a novel scavenging resin for clusterin, a persistent CHO host cell protein commonly observed in monoclonal antibody manufacturing processes.
Key Takeaways:
Understand platform process for the generation of highly specific VHH antibody-based ligands and affinity resin development for bioproduction.
Analyze performance data and sample chromatography condition for POROSTM CaptureSelectTM ClusterinClear affinity resin.
Review custom resin development process and timeline.
Just fill out the form below to view the recorded webcast now.